Cryptococcosis by Cryptococcus gattii is endemic in Colombia, affecting mostly immunocompetent hosts. Since antifungal susceptibility differs between molecular types of cryptococcal isolates, as reported elsewhere, the aim of this study was to determine if 42 Colombian clinical isolates, VGI, VGII and VGIII, differ in the susceptibility to commonly used antifungals, using Sensititre plates. Among the molecular types, six non-wild type isolates to fluconazole, voriconazole and 5-flucytosine, were identified. Besides, VGI and VGII were less susceptible to 5-flucytosine and azoles, respectively, than other molecular types. These findings support the applicability of practicing susceptibility testing, which could better guide treatment in cryptococcosis.
|Idioma original||Inglés estadounidense|
|Número de páginas||1125|
|Fecha en línea anticipada||jul. 15 2021|
|Estado||Publicada - nov. 2021|
|Evento||Congress on Trends in Medical Mycology - Aberdeen, Reino Unido|
Duración: oct. 8 2021 → oct. 11 2021
Número de conferencia: 10th